Vanqua Bio
Dr. Summers has over 30 years of drug discovery and pharmaceutical research management experience. He currently serves on the board of directors, and scientific advisory board, and as an advisor to several biotechnology companies and venture capital firms.
Previously, Jim was Vice President of Neuroscience Research at AbbVie, where he led efforts located in Ludwigshafen Germany, Lake County, IL, and Cambridge, MA focused on the discovery of new drugs for the treatment of Alzheimer’s and Parkinson’s diseases, pain, and psychiatric disorders. Under his leadership, teams have advanced more than twenty compounds into clinical development. Jim established new research sites in Cambridge Massachusetts and Shanghai China, was an architect of several strategies that defined the future direction of global research organizations, and championed multiple successful out-licensing deals, biotech collaborations, and venture investments.
Jim earned a Bachelor of Science degree, summa cum laude, in chemistry from Denison University and a doctorate in organic chemistry from Harvard University.
This person is not in the org chart
This person is not in any offices
Vanqua Bio
Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).